The government and stakeholders, as stewards, have designed and jointly implemented many positive reforms over the life of the PBS. Critical to that has been a commitment to good ideas, win-win outcomes, respect for the system and each other, and reforms that benefit patients and the system. Is any of that evident in 2024 as the system enters another period of change?
Where are the stewards to maintain and protect this critical public health program?
March 18, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Vitex opens $250 million pharmaceutical manufacturing facility in Western Sydney
July 6, 2026 - - Latest News -
Early clinical imaging shows Syntara candidate reduces brain inflammation in people at high risk of Parkinson’s
July 6, 2026 - - Australian Biotech -
Widespread use of statins narrows heart-risk gap between overweight and normal-weight adults
July 6, 2026 - - Latest News -
A performative change that still leaves the door open for a response to 'MFN' risk
July 6, 2026 - - Latest News -
New law proposes limiting trade minister's power over PBS concessions
July 6, 2026 - - Latest News -
The 'Dispatched' Podcast - Season 5, Episode 22
July 3, 2026 - - Podcast -
Is that a subtle but meaningful shift conceding the potential need for a response to global realities?
July 3, 2026 -

